This feels like science fiction, but it’s true! The conversation you’re about to hear is about the next innovation in pump technology that is going to revolutionize management for people using insulin. I’m joined by Xeris Pharmaceuticals CEO Paul Edict and Beta Bionics CEO Sean Saint a week after they announced a collaboration to develop a bi-hormonal pump that has both insulin and glucagon.
Time Stamps:
- (02:45) Paul’s background and role at Xeris
- (04:34) Sean’s background and role at Beta Bionics
- (06:16) How this epic collaboration came to be
- (08:33) Xeris on rescue glucagon
- (10:05) “We’re not there yet, but we’ll do it together”
- (10:41) The spirit of innovation
- (11:25) What hasn’t this been done before?
- (13:05) “But what’s going to happen to Gvoke pen?”
- (14:40) What can people get excited about?
- (16:00) The burden impact
- (16:57) The gas and brake
- (17:50) How is this different than AID delivery systems?
- (20:05) The extreme fear of low blood sugar
- (22:00) Anticipating possibilities and blocks
- (23:22) When we can expect this and FDA approval
- (26:51) Innovating in spite of a cure
- (30:24) Saving lives
What to do now:
- Follow me @lauren_bongiorno and @riselyhealth on Instagram to stay in the loop for when new episodes drop.
- Learn more about our 1:1 coaching programs HERE.
- Listen to Paul in our prior episode on Glucagon EPISODE 96
Disclaimer: Nothing you hear on the Reclaim your Rise podcast should be a substitute for personalized professional medical advice. Please always consult your physician or other medical professional before making any changes to your diet, insulin dosages, or healthcare plan.
